AVTX SCHEDULE 13G/A: SEC filing

Biotechnology Value Fund and affiliated entities

Filed with the SEC on · accession 0000921895-26-003170

AVTX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Biotechnology Value Fund and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 1.7% of Avalo Therapeutics' common stock as of September 30, 2026, a passive investment position.

Key details

Shares beneficially owned by BVF Partners L.P. (aggregate)$907K
Shares beneficially owned by Biotechnology Value Fund, L.P.$469K
Shares beneficially owned by Biotechnology Value Fund II, L.P.$353K
Shares beneficially owned by Biotechnology Value Trading Fund OS LP$66K
Reporting person / beneficial owner of 469,361 sharesBiotechnology Value Fund, L.P.
Reporting person / beneficial owner of 353,075 sharesBiotechnology Value Fund II, L.P.
Reporting person / beneficial owner of 65,625 sharesBiotechnology Value Trading Fund OS LP
Reporting person / investment manager, may be deemed beneficial owner of 907,406 sharesBVF Partners L.P.
Reporting person / general partner of bvf partners, may be deemed beneficial owner of 907,406 sharesBVF Inc.
IssuerAvalo Therapeutics, Inc.
Director and officer of bvf inc.Mark N. Lampert

✦ Ask GOAX AI about this filing — what it means for AVTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AVTX?

Click here

Frequently asked questions

What did AVTX file with the SEC on Nov 16, 2026?

AVTX filed a SCHEDULE 13G/A (SEC filing). Biotechnology Value Fund and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 1.7% of Avalo Therapeutics' common stock as of September 30, 2026, a passive investment position.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other AVTX SEC filings

Get alerts when AVTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days